Literature DB >> 20924881

Erectile dysfunction in opioid users: lack of association with serum testosterone.

Patricia A Cioe1, Peter D Friedmann, Michael D Stein.   

Abstract

This study describes the prevalence of erectile dysfunction (ED) among 57 men using illicit opioids who presented to a primary care program for buprenorphine therapy. Participants' mean age was 40 years and 34% reported ED. Low total testosterone was detected in 17% of those reporting ED, but total testosterone was not significantly associated with ED. Examining multiple comorbidities and laboratory parameters, only older age was significantly associated with ED (r = .27, P< .05). ED is highly prevalent among men abusing opioids, but low total testosterone is rarely the cause.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924881      PMCID: PMC2951625          DOI: 10.1080/10550887.2010.509279

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  30 in total

1.  The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Authors:  Steven A Grover; Ilka Lowensteyn; Mohammed Kaouache; Sylvie Marchand; Louis Coupal; Emidio DeCarolis; Joseph Zoccoli; Isabelle Defoy
Journal:  Arch Intern Med       Date:  2006-01-23

2.  Elevated sex hormone binding globulin levels may contribute to sexual dysfunction in men with chronic hepatitis C virus infection.

Authors:  Jyoti Rao; Ann Danoff; Edmund J Bini
Journal:  J Clin Gastroenterol       Date:  2009-01       Impact factor: 3.062

3.  Prevalence and risk factors for erectile dysfunction in the US.

Authors:  Elizabeth Selvin; Arthur L Burnett; Elizabeth A Platz
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

4.  Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.

Authors:  H V Nguyen; L C Mollison; T W Taylor; S A P Chubb; B B Yeap
Journal:  Intern Med J       Date:  2006-06       Impact factor: 2.048

5.  Sexual function in men older than 50 years of age: results from the health professionals follow-up study.

Authors:  Constance G Bacon; Murray A Mittleman; Ichiro Kawachi; Edward Giovannucci; Dale B Glasser; Eric B Rimm
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

6.  Prevalence of androgen deficiency in men with erectile dysfunction.

Authors:  Tobias S Köhler; Johnny Kim; Kendall Feia; Josh Bodie; Nick Johnson; Antoine Makhlouf; Manoj Monga
Journal:  Urology       Date:  2008-03-03       Impact factor: 2.649

7.  Adequacy of sexual performance in men maintained on methadone.

Authors:  R Hanbury; M Cohen; B Stimmel
Journal:  Am J Drug Alcohol Abuse       Date:  1977       Impact factor: 3.829

8.  Hypogonadism in men consuming sustained-action oral opioids.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2002-10       Impact factor: 5.820

9.  The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study.

Authors:  Amy B O'Donnell; Andre B Araujo; Irwin Goldstein; John B McKinlay
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

10.  A relationship of sex hormone levels and erectile dysfunction: which tests should be done routinely?

Authors:  Talha Müezzinoğu; Bilal Gümüş; Gökhan Temeltaş; Zeki Ari; Coşkun Büyüksu
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

View more
  9 in total

1.  Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders.

Authors:  Engin Emrem Bestepe; Nazlı Tunali; Gökçe Elif Sarıdoğan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-12       Impact factor: 2.570

Review 2.  Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors:  A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

3.  Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy.

Authors:  Patricia A Cioe; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2013-07-23

Review 4.  Sexual dysfunction in patients with alcohol and opioid dependence.

Authors:  Sandeep Grover; Surendra K Mattoo; Shreyas Pendharkar; Venkatesh Kandappan
Journal:  Indian J Psychol Med       Date:  2014-10

5.  The Evaluation of Relationship between Sexual Self-concept and Sexual Dysfunction in Individuals Undergoing Methadone Maintenance Treatment.

Authors:  Ghodratolah Rajabizadeh; Fatemeh Yazdanpanah; Mohammad Arash Ramezani
Journal:  Addict Health       Date:  2017-04

6.  Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy.

Authors:  Surendra K Mattoo; Abhishek Ghosh; B N Subodh; Debasish Basu; Ashirbad Satapathy; Sambhu Prasad; Mahendra Prakash Sharma
Journal:  Indian J Psychiatry       Date:  2020-01-03       Impact factor: 1.759

7.  Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.

Authors:  Anne Yee; Mahmoud Danaee; Huai Seng Loh; Ahmad Hatim Sulaiman; Chong Guan Ng
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

8.  Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.

Authors:  Fabio Lugoboni; Lorenzo Zamboni; Angela Federico; Stefano Tamburin
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

9.  Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study.

Authors:  Lei Zhang; Feng Cheng; Shu Su; Shunxiang Li; Shifu Li; Jun Jing; Christopher Kincaid Fairley; Liang Chen; Jinxian Zhao; Limin Mao
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.